Have a feature idea you'd love to see implemented?
Let us know!
FLGT Fulgent Genetics Inc
Price (delayed)
$16.95
Market cap
$518.45M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.52
Enterprise value
$460.82M
Fulgent Genetics' proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high
Highlights
Fulgent Genetics's debt has plunged by 86% YoY
FLGT's gross margin is up by 12% year-on-year but it is down by 7% since the previous quarter
The gross profit has contracted by 12% from the previous quarter but it has grown by 9% YoY
FLGT's EPS has dropped by 162% year-on-year
The net income has plunged by 160% YoY
Key stats
What are the main financial stats of FLGT
Market
Valuations
Earnings
Shares outstanding
30.59M
Market cap
$518.45M
Enterprise value
$460.82M
Price to book (P/B)
0.45
Price to sales (P/S)
1.86
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.66
Revenue
$277.76M
EBIT
-$182.11M
EBITDA
-$152.04M
Free cash flow
-$28.02M
Per share
Balance sheet
Liquidity
EPS
-$5.52
Free cash flow per share
-$0.92
Book value per share
$37.58
Revenue per share
$9.13
TBVPS
$35.33
Total assets
$1.23B
Total liabilities
$98.87M
Debt
$412,000
Equity
$1.14B
Working capital
$252.55M
Debt to equity
0
Current ratio
4.41
Quick ratio
3.65
Net debt/EBITDA
0.38
Margins
Efficiency
Dividend
EBITDA margin
-54.7%
Gross margin
36.2%
Net margin
-59.4%
Operating margin
-75.2%
Return on assets
-13.4%
Return on equity
-14.5%
Return on invested capital
-19.6%
Return on capital employed
-15.7%
Return on sales
-65.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
FLGT stock price
How has the Fulgent Genetics stock price performed over time
Intraday
-1.91%
1 week
-4.72%
1 month
-12.31%
1 year
-38%
YTD
-41.37%
QTD
-22%
Financial performance
How have Fulgent Genetics's revenue and profit performed over time
Revenue
$277.76M
Gross profit
$100.6M
Operating income
-$208.9M
Net income
-$164.97M
Gross margin
36.2%
Net margin
-59.4%
Fulgent Genetics's net margin has plunged by 168% YoY and by 6% from the previous quarter
Fulgent Genetics's operating margin has plunged by 166% YoY and by 14% from the previous quarter
The net income has plunged by 160% YoY
Fulgent Genetics's operating income has plunged by 158% YoY and by 9% from the previous quarter
Growth
What is Fulgent Genetics's growth rate over time
Valuation
What is Fulgent Genetics stock price valuation
P/E
N/A
P/B
0.45
P/S
1.86
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.66
FLGT's EPS has dropped by 162% year-on-year
The price to book (P/B) is 76% lower than the 5-year quarterly average of 1.9 and 25% lower than the last 4 quarters average of 0.6
The company's equity fell by 10% YoY
FLGT's P/S is 45% below its 5-year quarterly average of 3.4 and 23% below its last 4 quarters average of 2.4
Fulgent Genetics's revenue has decreased by 4.5% QoQ and by 3% YoY
Efficiency
How efficient is Fulgent Genetics business performance
The company's return on assets has shrunk by 191% YoY and by 3.9% QoQ
The return on equity has dropped by 190% year-on-year and by 3.6% since the previous quarter
FLGT's ROS is down by 22% since the previous quarter
The company's return on invested capital fell by 16% QoQ
Dividends
What is FLGT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for FLGT.
Financial health
How did Fulgent Genetics financials performed over time
FLGT's quick ratio has dropped by 57% year-on-year and by 25% since the previous quarter
FLGT's current ratio has dropped by 51% year-on-year and by 16% since the previous quarter
Fulgent Genetics's debt is 100% less than its equity
Fulgent Genetics's debt has plunged by 86% YoY
The company's equity fell by 10% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.